West Pharmaceutical Services, Inc. WST
- Market cap
- $26.3B
- P/E
- 47.1×
Follow WST
West Pharmaceutical Services, Inc. (WST) EV/Sales
As of 25 September 2026, West Pharmaceutical Services, Inc. (WST) trades at a EV/Sales of 7.8×. Over the past ten years it has ranged from 2.5× (February 2015) to 13.6× (September 2021); the current reading is higher than 67% of that period. That is above the Medical Instruments & Supplies industry median of 3.1× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 6.3× | (23.11%) |
| FY2024 | 8.2× | (4.12%) |
| FY2023 | 8.5× | 46.79% |
| FY2022 | 5.8× | (52.15%) |
| FY2021 | 12.1× | 26.55% |
| FY2020 | 9.6× | 61.17% |
| FY2019 | 5.9× | 43.77% |
| FY2018 | 4.1× | (9.58%) |
| FY2017 | 4.6× | 11.59% |
| FY2016 | 4.1× | 33.74% |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 7.6× | 37.55% |
| Mar 2026 | 5.5× | (12.36%) |
| Dec 2025 | 6.3× | 2.36% |
| Sep 2025 | 6.1× | 17.24% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDLN Medline Inc. compare | 1.3× |
| BAX Baxter International Inc. compare | 1.7× |
| SOLV Solventum Corporation compare | 2.4× |
| BDX Becton, Dickinson and Company compare | 2.8× |
| COO The Cooper Companies, Inc. compare | 3.1× |
| ALC Alcon compare | 3.2× |
| RMD ResMed Inc. compare | 5.5× |
| WST West Pharmaceutical Services, Inc. | 7.8× |
| RGEN Repligen Corporation compare | 13.4× |
| Medical Instruments & Supplies industry median | 3.1× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on WST
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement